Anti-GP150/ GPR150/ PGR11 monoclonal antibody

Anti-GP150/ GPR150/ PGR11 antibody for FACS & in-vivo assay

Target products collectionGo to GPR150/GPR150 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0513-Ab-1/ GM-Tg-hg-MP0513-Ab-2Anti-Human GPR150 monoclonal antibodyHuman
GM-Tg-rg-MP0513-Ab-1/ GM-Tg-rg-MP0513-Ab-2Anti-Rat GPR150 monoclonal antibodyRat
GM-Tg-mg-MP0513-Ab-1/ GM-Tg-mg-MP0513-Ab-2Anti-Mouse GPR150 monoclonal antibodyMouse
GM-Tg-cynog-MP0513-Ab-1/ GM-Tg-cynog-MP0513-Ab-2Anti-Cynomolgus/ Rhesus macaque GPR150 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0513-Ab-1/ GM-Tg-felg-MP0513-Ab-2Anti-Feline GPR150 monoclonal antibodyFeline
GM-Tg-cang-MP0513-Ab-1/ GM-Tg-cang-MP0513-Ab-2Anti-Canine GPR150 monoclonal antibodyCanine
GM-Tg-bovg-MP0513-Ab-1/ GM-Tg-bovg-MP0513-Ab-2Anti-Bovine GPR150 monoclonal antibodyBovine
GM-Tg-equg-MP0513-Ab-1/ GM-Tg-equg-MP0513-Ab-2Anti-Equine GPR150 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0513-Ab-1/ GM-Tg-hg-MP0513-Ab-2; GM-Tg-rg-MP0513-Ab-1/ GM-Tg-rg-MP0513-Ab-2;
GM-Tg-mg-MP0513-Ab-1/ GM-Tg-mg-MP0513-Ab-2; GM-Tg-cynog-MP0513-Ab-1/ GM-Tg-cynog-MP0513-Ab-2;
GM-Tg-felg-MP0513-Ab-1/ GM-Tg-felg-MP0513-Ab-2; GM-Tg-cang-MP0513-Ab-1/ GM-Tg-cang-MP0513-Ab-2;
GM-Tg-bovg-MP0513-Ab-1/ GM-Tg-bovg-MP0513-Ab-2; GM-Tg-equg-MP0513-Ab-1/ GM-Tg-equg-MP0513-Ab-2
Products NameAnti-GPR150 monoclonal antibody
Formatmab
Target NameGPR150
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GPR150 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GP150/ GPR150/ PGR11 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0513
    Target NameGPR150
    Gene ID285601,238725,499486,698491,119871103,101088215,112447493,102148028
    Gene Symbol and SynonymsC030001A19Rik,GPR150,PGR11,RGD1564729
    Uniprot AccessionQ8NGU9
    Uniprot Entry NameGP150_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000178015
    Target ClassificationGPCR

    The target: GPR150, gene name: GPR150, also named as PGR11. This gene encodes an orphan member of the class A rhodopsin-like family of G-protein-coupled receptors (GPCRs). Within the rhodopsin-like family, this gene is a member of the vasopressin-like subfamily that also includes vasopressin and oxytocin receptors. The silencing of this gene, due to promoter methylation, is associated with ovarian cancer progression. All GPCRs have a transmembrane domain that includes seven transmembrane alpha-helices. A general feature of GPCR signaling is the agonist-induced conformational change in the receptor, leading to activation of the heterotrimeric G protein. The activated G protein then binds to and activates numerous downstream effector proteins, which generate second messengers that mediate a broad range of cellular and physiological processes. [provided by RefSeq, Jul 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.